Teclistamab for Multiple Myeloma Therapy: A Literature Review and the First Clinical Use in Russia
The modern paradigm for the treatment of hematologic tumors can hardly be imagined without immunotherapy including the most rapidly developing group of drugs referred to as bispecific antibodies. Teclistamab is a humanized bispecific antibody created for targeted impact on the B-cell maturation anti...
Guardat en:
| Autors principals: | , , , , , , |
|---|---|
| Format: | Artigo |
| Idioma: | Russo |
| Publicat: |
Practical Medicine Publishing House
2025-10-01
|
| Col·lecció: | Клиническая онкогематология |
| Matèries: | |
| Accés en línia: | https://bloodjournal.ru/index.php/coh/article/view/728 |
| Etiquetes: |
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|